Efficacy of CROWN in Repair and Maintenance of the Intestinal Mucosa in Patients With CD Receiving Anti-TNF Therapy
Status:
Terminated
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate CROWN's efficacy in supporting the repair and
maintenance of the intestinal mucosa of patients with moderately to severely active Crohn's
Disease receiving anti-Tumor Necrosis Factor (TNF) therapy (infliximab, adalimumab,
certolizumab)